創薬における人工知能(AI) の世界市場は、2023年の16億ドルから2028年までに57億ドルに拡大し、2023年から2028年までのCAGRは 29.6%になると推定されます。
目次
Chapter- 1: Introduction
Overview
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Chapter- 2: Summary and Highlights
Market Outlook
Market Insights
Chapter- 3: Market Overview
Introduction
Future Perspectives
Chapter- 4: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Chapter- 5: Regulatory Landscape and Reimbursement Scenario
Regulatory Landscape
Chapter- 6: Impact of COVID-19 on Market
Overview
Chapter- 7: Market Breakdown by Application
Applications of AI in Drug Discovery
Chapter- 8: Market Breakdown by Therapeutic Area
AI in Drug Discovery by Therapeutic Area
Chapter- 9: Market Breakdown by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 10: ESG Development
Introduction to ESG
Chapter- 11: Emerging Technologies and Developments
Overview
Current Market Trends
Emerging Technologies
Chapter- 12: M&A and Funding Outlook
M&A Analysis
Chapter- 13: Competitive Landscape
Competitive Analysis
Company Share Analysis
Chapter- 14: Company Profiles
ARIA PHARMACEUTICALS INC.
ATOMWISE INC.
BENEVOLENTAI
EXSCIENTIA PLC
INSILICO MEDICINE
RECURSION PHARMACEUTICALS INC.
RELAY THERAPEUTICS INC.
SCHRODINGER INC.
XTALPI INC.
Chapter- 15: Appendix: Acronyms
Table 78 : Acronyms Used in This Report
